Non-specific plasma constituents

Non-specific plasma constituents refer to the heterogeneous collection of proteins, electrolytes, lipids, and other molecules found within the liquid portion of blood. This term does not describe a single molecular target but rather a physiological compartment that significantly influences the pharmacokinetics and pharmacodynamics of various therapeutic agents [1]. The primary components, such as albumin and alpha-1-acid glycoprotein, serve as major reservoirs for drug binding, which determines the free fraction of a drug available to reach its intended site of action [2]. While these constituents are vital for maintaining oncotic pressure and systemic homeostasis, they are typically viewed as factors affecting drug disposition rather than targets for direct pharmacological modulation [3]. Understanding the interaction between drugs and these plasma components is essential for predicting drug-drug interactions and adjusting dosages in patients with altered plasma protein profiles [4]. Consequently, this category is often used in pharmacological databases to denote non-specific interactions or systemic effects that cannot be attributed to a single receptor or enzyme [5]. In clinical settings, monitoring these constituents is crucial for managing conditions like hypoalbuminemia or electrolyte imbalances that can alter drug safety profiles [6]. (Citations: [1] StatPearls, 2023, Physiology, Plasma Proteins; [2] Smith, D. A., et al., 2010, Pharmacokinetics and Metabolism in Drug Design; [3] Trainor, G. L., 2007, Expert Opinion on Drug Discovery; [4] PubMed, 2021, Clinical Significance of Protein Binding; [5] IUPHAR/BPS Guide to Pharmacology, 2024; [6] Merck Manual, 2023, Plasma Proteins and Drug Distribution).

Other names

Plasma proteinsSerum constituentsBlood plasma componentsPlasma fraction

Non-specific binding and transport of exogenous substances